Lisdexamfetamine, marketed as Vyvanse, is a controlled medication indicated for attention deficit hyperactivity disorder in children and adults . In Canada, its distribution is strictly regulated by Health Canada. This resource seeks to present concise information on its therapeutic applications … Read More